(Q34635431)

3 August 2017

1 reference

title

Targets for therapy of the painful bladder (English)

1 reference

3 August 2017

1

Alan J Wein

1 reference

3 August 2017

Philip M Hanno

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

59

1 reference

3 August 2017

issue

5 Suppl 1

1 reference

3 August 2017

page(s)

68-73

1 reference

Interstitial cystitis: current issues and controversies in diagnosis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

The epidemiology of interstitial cystitis: is it time to expand our definition?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Interstitial cystitis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Epidemiology of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Interstitial cystitis in The Netherlands: prevalence, diagnostic criteria and therapeutic preferences

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Epidemiology of interstitial cystitis: a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Associations among cystoscopic and urodynamic findings for women enrolled in the Interstitial Cystitis Data Base (ICDB) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

A model for the function of glycosaminoglycans in the urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

An assessment of the use of intravesical potassium in the diagnosis of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Mast cell involvement in interstitial cystitis: a review of human and experimental evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Estrogen and neuroinflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Targeting afferent hyperexcitability for therapy of the painful bladder syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor–like growth factor, and epidermal growth factor as urine markers for interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Urine markers of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

The use of amitriptyline in patients with urinary frequency and pain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

The Use of Dimethyl Sulfoxide (DMSO) in the Treatment of Interstitial Cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

A controlled study of dimethyl sulfoxide in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis--a practical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Dimethyl sulfoxide does not trigger urine histamine release in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Long-term experience with pentosanpolysulfate in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Hydroxyzine therapy for interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Cimetidine in treatment of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Clinical response to an oral prostaglandin analogue in patients with interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Effects of L-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Treatment of interstitial cystitis with intravesical heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Recombinant human nerve growth factor in the treatment of interstitial cystitis: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

Sacral nerve stimulation in patients with chronic, intractable pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901640-5

7 January 2021

10.1016/S0090-4295(01)01640-5

Identifiers

DOI

1 reference

3 August 2017

1 reference